Desai Xiwei: the net profit in 2021 will increase by 54% - 64% year-on-year

Beyond Capital: Why Europe Needs Industrial Partners, Not Just Investors

Europe’s reindustrialization is creating new opportunities for Chinese companies. However, the winners will not necessarily be those seeking quick acquisitions or rapid market access. The real opportunities belong to companies capable of embedding themselves into Europe’s industrial ecosystem and supporting the long-term transformation of local industries.

Kanghong’s Conbercept Receives Marketing Authorization in Guyana

Kanghong Pharmaceutical (康弘药业) said its subsidiary Kanghong Bioscience had received a drug registration certificate from Guyana’s Food and Drug Department for conbercept ophthalmic injection, marketed under the brand name Lumitin (朗沐).

SHEIN Reportedly Targets US$26–27 Billion Valuation in Hong Kong IPO

SHEIN (希音), the China-founded global fashion and lifestyle retailer, is reportedly seeking a valuation of US$26 billion to US$27 billion in a planned Hong Kong initial public offering, a sharp reduction from the US$98.2 billion private-market valuation disclosed for its 2022 fundraising round.

Li Auto, Nvidia and Desay SV Automotive Sign a Tripartite Agreement 

Li Auto's second product, a full-sized SUV, will be the first to use Nvidia's Orin system-on-chip product. 

Self-driving and IoV to be New Business Engines for Desay SV

The intelligent cockpit has been the firm’s core business, taking up 90% of revenues; Desay SV is pivoting towards ADAS and IoV to capture opportunities in the era of autonomous driving.